Data as of .
BIOY vs GPTY: which paid, and which earned it?
BIOY and GPTY both write options for income.
What they hold in common
By the books each fund has filed, BIOY and GPTY hold 0% of their money in the same securities at the same weight.
| Only in BIOY | Only in GPTY |
|---|---|
| Treasury Bill 100.00% | Intel Corp 9.47% |
| Advanced Micro Devices Inc 6.95% | |
| Alphabet Inc 6.81% | |
| NVIDIA Corp 6.73% | |
| Marvell Technology Inc 5.60% | |
| TSMC 5.52% | |
| Broadcom Inc 4.82% | |
| Palantir Technologies Inc 4.37% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Apr 30, 2026 and Jun 30, 2026.
Performance, window by window
| Window | Total return | Cash paid | Against the benchmark | |||
|---|---|---|---|---|---|---|
| BIOY | GPTY | BIOY | GPTY | BIOY | GPTY | |
| 3 months | +2.5% | −1.3% | 14.1% | 8.2% | −9.0 pts | −0.5 pts |
| 6 months | not published | +40.4% | not published | 22.2% | not published | −0.1 pts |
| 1 year | not published | +32.4% | not published | 34.0% | not published | −5.7 pts |
| Since launch | +2.0% | +53.2% | 20.6% | 51.0% | −15.3 pts | −4.9 pts |
| BIOY GraniteShares YieldBOOST Biotech ETF Synthetic covered call on XBI, paying weekly | GPTY YieldMax(R) AI & Tech Portfolio Option Income ETF Synthetic covered call on XLK, paying weekly | |
|---|---|---|
| Issuer | GraniteShares | YieldMax |
| Strategy | synthetic covered call | synthetic covered call |
| Benchmark | Biotech (XBI), used as the proxy | Technology sector (XLK) |
| Pays | weekly | weekly |
| Payout rate, annualized | 60.0% | 35.3% |
| Expense ratio | 1.07% | 1.06% |
| Cash paid, 1 year | 20.6% (since launch on May 5, 2026) | 34.0% |
| Price change, 1 year | −19.0% | −8.1% |
| Total return, 1 year | +2.0% (since launch on May 5, 2026) | +32.4% |
| Benchmark return, 1 year | +17.3% | +38.0% |
| Ahead or behind | −15.3 pts | −5.7 pts |
| Return of capital, latest estimate | 96% | 94% |
| Age | 136 days | 603 days |
| Net assets | $1m | $126m |
BIOY in plain words
Over the period since launch on May 5, 2026 to Sep 18, 2026, BIOY paid 20.6% of its starting value in cash distributions while its price fell 19.0%. With every distribution reinvested, the fund returned +2.0%. Biotech (XBI), used as the proxy returned +17.3% over the same days, so a holder was behind by 15.3 pts. At its price on Sep 18, 2026 the latest distribution annualizes to 60.0%, paid weekly. GraniteShares estimates that 96% of the distribution paid Aug 25, 2026 was a return of capital (19a-1 notice, estimated, a tax characterization rather than a measure of erosion).
GPTY in plain words
Over the year to Sep 18, 2026, GPTY paid 34.0% of its starting value in cash distributions while its price fell 8.1%. With every distribution reinvested, the fund returned +32.4%. Technology sector (XLK) returned +38.0% over the same days, so a holder was behind by 5.7 pts. At its price on Sep 18, 2026 the latest distribution annualizes to 35.3%, paid weekly. YieldMax estimates that 94% of the distribution paid Sep 17, 2026 was a return of capital (19a-1 notice, estimated, a tax characterization rather than a measure of erosion).
Questions people ask
- Which is cheaper, BIOY or GPTY?
- BIOY charges 1.07% a year and GPTY charges 1.06%, so GPTY is cheaper. Fees come from each fund's prospectus.
Other comparisons
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, BIOY against GPTY, data as of Sep 18, 2026. https://etfiq.com/compare/income/bioy-vs-gpty Free to use with attribution; the underlying files are at Open data.